US3853893A
(en)
*
|
1973-04-02 |
1974-12-10 |
Squibb & Sons Inc |
Anthelmintic 5-(pyridyl)-3-(isothiocyanophenyl) oxadiazoles
|
HU177086B
(en)
*
|
1975-06-09 |
1981-07-28 |
Eszakmagyar Vegyimuevek |
Herbicide and fungicide preparation containing substituted 1,2,4-oxadiazolidin-3-one derivatives
|
JPS58150576A
(ja)
*
|
1982-03-03 |
1983-09-07 |
Sumitomo Chem Co Ltd |
新規な1,2,4−オキサジアゾ−ル誘導体
|
DE3247118A1
(de)
*
|
1982-12-20 |
1984-06-20 |
Cassella Ag, 6000 Frankfurt |
Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
NZ517221A
(en)
*
|
1999-08-19 |
2004-01-30 |
Nps Pharma Inc |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
US6660753B2
(en)
*
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
EP1582519A3
(en)
*
|
1999-08-19 |
2005-12-21 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
MXPA03007513A
(es)
*
|
2001-02-21 |
2004-07-30 |
Nps Pharma Inc |
Compuestos heteropoliciclicos y su uso como antagonistas del receptor metabotropico de glutamato.
|
CA2495179A1
(en)
|
2002-08-09 |
2004-02-19 |
Astrazeneca Ab |
Compounds having an activity at metabotropic glutamate receptors
|
US8178570B2
(en)
*
|
2003-04-09 |
2012-05-15 |
Exelixis, Inc. |
Tie-2 modulators and methods of use
|
US20060252741A1
(en)
*
|
2003-05-15 |
2006-11-09 |
Colandrea Vincent J |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
|
US20060189661A1
(en)
*
|
2003-11-03 |
2006-08-24 |
Wagenen Bradford V |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
WO2005060961A2
(en)
*
|
2003-12-18 |
2005-07-07 |
Astrazeneca Ab |
Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd)
|
US8207147B2
(en)
*
|
2003-12-24 |
2012-06-26 |
Prosidion Limited |
Heterocyclic derivatives as GPCR receptor agonists
|
WO2005077368A2
(en)
*
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
AU2006239418A1
(en)
|
2005-04-26 |
2006-11-02 |
Neurosearch A/S |
Novel oxadiazole derivatives and their medical use
|
IL169855A
(en)
*
|
2005-07-25 |
2014-05-28 |
Elta Systems Ltd |
A system and method for locating a receiver location
|
NZ565460A
(en)
|
2005-07-26 |
2011-06-30 |
Bial Portela & Ca Sa |
Nitrocatechol derivatives as COMT inhibitors
|
EP1845097A1
(en)
|
2006-04-10 |
2007-10-17 |
Portela & Ca., S.A. |
Oxadiazole derivatives as COMT inhibitors
|
TWI392671B
(zh)
*
|
2006-09-07 |
2013-04-11 |
Actelion Pharmaceuticals Ltd |
吡啶-4-基衍生物
|
PL2069335T3
(pl)
*
|
2006-09-08 |
2013-05-31 |
Actelion Pharmaceuticals Ltd |
Pochodne pirydyn-3-ylu jako środki immunomodulujące
|
US8524746B2
(en)
|
2007-01-31 |
2013-09-03 |
Bial-Portela & Ca., S.A. |
Dosage regimen for COMT inhibitors
|
DK2125797T3
(da)
*
|
2007-03-16 |
2014-02-10 |
Actelion Pharmaceuticals Ltd |
Aminopyridinderivater som s1p1/edg1-receptoragonister
|
WO2009024905A1
(en)
*
|
2007-08-17 |
2009-02-26 |
Actelion Pharmaceuticals Ltd |
Pyridine derivatives as s1p1/edg1 receptor modulators
|
CA2715802A1
(en)
*
|
2008-02-28 |
2009-09-03 |
Bial - Portela & C.A., S.A. |
Pharmaceutical composition for poorly soluble drugs
|
JP5411877B2
(ja)
*
|
2008-03-06 |
2014-02-12 |
アクテリオン ファーマシューティカルズ リミテッド |
ピリジン化合物
|
KR101615779B1
(ko)
*
|
2008-03-07 |
2016-04-26 |
액테리온 파마슈티칼 리미티드 |
면역조절제로서 피리딘-2-일 유도체
|
AR070907A1
(es)
|
2008-03-17 |
2010-05-12 |
Bial Portela & Ca Sa |
Formas cristalinas de derivado de nitrocatecol
|
PT2291080E
(pt)
*
|
2008-05-14 |
2015-10-30 |
Scripps Research Inst |
Novos modelamodeladores dos recetores da esfingosina fosfato
|
HUE046023T2
(hu)
|
2009-02-10 |
2020-01-28 |
Monsanto Technology Llc |
Készítmények és eljárások nematódák irtására
|
ES2730678T3
(es)
|
2009-04-01 |
2019-11-12 |
Bial Portela & Ca Sa |
Formulaciones farmacéuticas que comprenden derivados de nitrocatecol y métodos para fabricarlas
|
ES2915698T3
(es)
*
|
2009-04-01 |
2022-06-24 |
Bial Portela & Ca Sa |
Formulaciones farmacéuticas que comprenden derivados de nitrocatecol y métodos para preparar las mismas
|
RU2547098C2
(ru)
|
2009-07-16 |
2015-04-10 |
Актелион Фармасьютиклз Лтд |
Производные пиридин-4-ила
|
WO2012098505A1
(en)
|
2011-01-19 |
2012-07-26 |
Actelion Pharmaceuticals Ltd |
2-methoxy-pyridin-4-yl derivatives
|
US20140045900A1
(en)
|
2011-02-11 |
2014-02-13 |
Bial-Portela & Ca, S.A. |
Administration regime for nitrocatechols
|
HUE047856T2
(hu)
|
2011-12-13 |
2020-05-28 |
Bial Portela & Ca Sa |
Kémiai vegyület, amely köztitermékként használható katechol-O-metil-transzferáz inhibitor elõállításához
|
UY35327A
(es)
*
|
2013-02-15 |
2014-09-30 |
Monsanto Technology Llc |
?4,5-dihidro-1,2,4-oxadiazoles disustituidos en 3,5 y composiciones y métodos para controlar plagas de nematodos?.
|
WO2016083863A1
(en)
|
2014-11-28 |
2016-06-02 |
Bial - Portela & Ca, S.A. |
Medicaments for slowing parkinson's disease
|
HUE047646T2
(hu)
|
2015-05-20 |
2020-05-28 |
Idorsia Pharmaceuticals Ltd |
Az (S)-3-{4-[5-(2-ciklopentil-6-metoxi-piridin-4-il)-[1,2,4]oxadiazol-3-il]-2-etil-6-metil-fenoxi} -propán-1,2-diol vegyület kristályformája
|